CMS Update: the Latest Information, News and Resources
August 1, 2019

AACE Practice Management has gathered the latest news from the Centers of Medicare & Medicaid Services to help endocrinologists and their practices. For more information, please e-mail practicemanagement@aace.com.

  • If you ORDER nuclear medicine studies please be aware of the new requirements effective January 1, 2020!  Learn about the Appropriate Use Criteria (AUC) for ADI, related HCPCS procedure codes, modifiers and G codes.  Click here for the complete article.
  • What does it mean to “Promote Interoperability”? Click here to find out. 
  • Need Resources? Click here for help with ICD10, NCD/LCD, Claims Processing and Billing Guidance, Coding etc. from Medicare. 
  • The Measures Management System Overview from Medicare provides information about the Measures Management system (MMS), Quality Measure roles, Quality Measures Inventory and the process which developers submit measures to CMS for consideration.  Click here for newsletters and to subscribe to the MMS Listserv.
  • Are you familiar with the 1995 and 1997 E/M Guidelines from Medicare? Learn more here.
  • Get an up-to-date list of telehealth codes here.
  • What is Intensive Behavioral Therapy (IBT) for Obesity and can you report it? Find out here
  • Collecting Data on Sexual Orientation and Gender Identity in Health Care Settings Web-Based Training Course is available through the MLN Learning Management and Product Ordering System. Learn about:
    • Basic terminology for Lesbian, Gay, Bisexual and Transgender (LGBT) people
    • LGBT health needs and disparities
    • The importance of asking people about their SOGI in clinical settings
    • Why SOGI data should be collected and different ways to collect it in the clinical setting
    • Ways to implement SOGI questions into work flows with and without electronic health records
  • CMS kept all of the MIPS reporting measures that they instituted in the CY2019 Physician Fee Schedule Rule (Family Medicine, Internal Medicine, OB/GYN, Preventive Medicine, Rheumatology, Geriatrics, Orthopedic Surgery, Eurology, Oncology/Hematology, Radiation Oncology).
  • A new MIPS Quality Reporting Measure has been proposed to be added for Endocrinology that would ask for reporting on DXA Screening for (1) Osteoporosis for Women Aged 65-85, (2) Patients who have reported a fracture, and (3) Patients receiving chemo treatments for prostate cancer. This matches with other reporting requirements previously established. We did not choose to fight against the addition of MIPS Quality Reporting Measures during CY2019.
  • CMS proposes to remove a MIPS Quality Reporting Measure concerning DXA tests for those with Inflammatory Bowel Disease receiving Corticosteroid treatments. The measure would be removed for the 2022 MIPS Payment Year.